Anna Ludovica Fracanzani Selected Research

Insulin Resistance

1/2022	Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
9/2021	α-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study.
10/2019	mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance.
3/2014	A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia.
10/2011	Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target.
3/2011	Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C.
2/2011	Beyond hereditary hemochromatosis: new insights into the relationship between iron overload and chronic liver diseases.
9/2008	Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
5/2008	Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis.
3/2008	Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations: response to Equitani et al.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Ludovica Fracanzani Research Topics

Disease

47	Non-alcoholic Fatty Liver Disease 01/2024 - 02/2002
38	Fibrosis (Cirrhosis) 01/2024 - 05/2004
15	Fatty Liver 02/2024 - 02/2002
15	Insulin Resistance 01/2022 - 02/2002
14	Liver Cirrhosis (Hepatic Cirrhosis) 02/2024 - 08/2007
12	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 05/2004
10	Liver Diseases (Liver Disease) 02/2024 - 12/2005
9	Infections 05/2024 - 07/2005
9	Iron Overload 01/2021 - 08/2007
8	Inflammation (Inflammations) 11/2022 - 10/2006
8	Hyperferritinemia 01/2021 - 10/2006
7	COVID-19 05/2024 - 10/2020
7	Chronic Hepatitis C 10/2021 - 05/2002
7	Hemochromatosis (Bronze Diabetes) 12/2012 - 06/2007
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2012 - 06/2007
5	Atherosclerosis 07/2023 - 03/2011
5	Hepatitis 01/2022 - 08/2007
5	Hypertension (High Blood Pressure) 01/2022 - 09/2008
5	Siderosis 01/2021 - 02/2002
4	Obesity 03/2024 - 06/2007
4	Respiratory Insufficiency (Respiratory Failure) 11/2022 - 10/2020
4	Chronic Hepatitis (Chronic Active Hepatitis) 05/2008 - 05/2004
3	Portal Hypertension 12/2023 - 01/2018
3	Neoplasms (Cancer) 02/2023 - 10/2020
3	Alcoholism (Alcohol Abuse) 01/2020 - 01/2008
2	Hemorrhage 05/2024 - 01/2018
2	Weight Gain 02/2024 - 01/2022
2	Thalassemia 01/2024 - 01/2021
2	Thrombosis (Thrombus) 12/2023 - 01/2018
2	Ascites 01/2023 - 01/2020
2	Anemia 11/2022 - 01/2021
2	Pneumonia (Pneumonitis) 11/2022 - 02/2021
2	Hepatomegaly 01/2022 - 01/2020
2	Alcoholic Fatty Liver 01/2022 - 01/2017
2	Dyslipidemias (Dyslipidemia) 04/2021 - 01/2019
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021 - 10/2020
2	Type 2 Diabetes Mellitus (MODY) 11/2020 - 01/2016
2	Hepatitis C 01/2020 - 07/2005
2	Cryptogenic Cirrhosis 01/2017 - 02/2013
2	Abdominal Obesity 01/2012 - 06/2011
2	Glucose Intolerance 06/2011 - 02/2002
2	beta-Thalassemia (Cooley's Anemia) 11/2010 - 08/2007
1	Cytopenia 01/2024
1	Chronic Hepatitis B 02/2023
1	Hepatic Encephalopathy 01/2023
1	Bradycardia 01/2023

Drug/Important Bio-Agent (IBA)

26	IronIBA 11/2022 - 05/2002
16	Ferritins (Ferritin)IBA 01/2024 - 10/2006
10	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 01/2008
9	Proteins (Proteins, Gene)FDA Link 10/2020 - 05/2008
9	EnzymesIBA 10/2020 - 02/2002
8	LipidsIBA 02/2024 - 02/2010
8	Transaminases (Aminotransferases)IBA 01/2022 - 09/2008
7	Alanine Transaminase (SGPT)IBA 01/2023 - 09/2008
6	Antiviral Agents (Antivirals)IBA 02/2024 - 03/2011
6	Transferrin (beta 2 Transferrin)IBA 01/2021 - 08/2007
5	Triglycerides (Triacylglycerol)IBA 01/2023 - 09/2008
5	HepcidinsIBA 11/2022 - 08/2007
5	CytokinesIBA 02/2022 - 02/2002
5	Phospholipases (Phospholipase)IBA 11/2020 - 04/2010
4	Biomarkers (Surrogate Marker)IBA 02/2023 - 06/2011
4	Messenger RNA (mRNA)IBA 02/2020 - 05/2008
4	Insulin (Novolin)FDA Link 05/2016 - 06/2007
3	InterferonsIBA 12/2017 - 05/2002
3	AntioxidantsIBA 02/2010 - 07/2005
3	LDL CholesterolIBA 01/2008 - 12/2005
2	RNA (Ribonucleic Acid)IBA 03/2024 - 01/2022
2	SodiumIBA 10/2023 - 01/2023
2	nasIBA 07/2023 - 01/2018
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2023 - 01/2020
2	Oxygen (Dioxygen)IBA 06/2022 - 02/2021
2	CholesterolIBA 11/2021 - 01/2020
2	metal transporting protein 1 (ferroportin)IBA 01/2021 - 11/2010
2	CarbohydratesIBA 11/2020 - 10/2011
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2020 - 09/2010
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 01/2016
2	Nonesterified Fatty Acids (NEFA)IBA 01/2020 - 01/2015
2	Sterol Esterase (Hormone-Sensitive Lipase)IBA 12/2019 - 01/2017
2	MicroRNAs (MicroRNA)IBA 10/2019 - 12/2018
2	Methionine (L-Methionine)FDA Link 10/2019 - 04/2010
2	Telomerase (Telomerase Reverse Transcriptase)IBA 08/2017 - 02/2013
2	AdiponectinIBA 10/2015 - 08/2012
2	TransferasesIBA 03/2014 - 03/2011
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2014 - 06/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2005 - 02/2002
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 05/2024
1	Heparin (Liquaemin)FDA LinkGeneric 05/2024
1	luspaterceptIBA 01/2024
1	Hemostatics (Antihemorrhagics)IBA 12/2023
1	Sodium-Glucose Transport ProteinsIBA 10/2023
1	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2023
1	NAD (NADH)IBA 01/2023
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2023
1	remdesivirIBA 01/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2022

Therapy/Procedure

14	Therapeutics 05/2024 - 05/2002
2	Liver Transplantation 02/2013 - 05/2004
1	Length of Stay 01/2024
1	Drug Therapy (Chemotherapy) 10/2023
1	Patient Readmission 01/2023